Oncotarget

Meta-Analysis:

Diagnostic accuracy of DNA methylation in detection of gastric cancer: a meta-analysis

Weiling Hu _, Wenfang Zheng, Qifang Liu, Hua Chu, Shujie Chen, John J. Kim, Jiaguo Wu and Jianmin Si

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:113142-113152. https://doi.org/10.18632/oncotarget.22613

Metrics: PDF 1246 views  |   HTML 1301 views  |   ?  


Abstract

Weiling Hu1,2, Wenfang Zheng1,2, Qifang Liu1, Hua Chu1, Shujie Chen1,2, John J. Kim1,3, Jiaguo Wu1,2 and Jianmin Si1,2

1Department of Gastroenterology, Sir Run Run Shaw Hospital, Medical School, Zhejiang University, Hangzhou, China

2Institute of Gastroenterology, Zhejiang University, Hangzhou, China

3Division of Gastroenterology, Loma Linda University Medical Center, Loma Linda, CA, USA

Correspondence to:

Weiling Hu, email: huweiling@zju.edu.cn

Jianmin Si, email: sijm@zju.edu.cn

Keywords: gastric cancer, DNA methylation, blood, non-invasive, diagnosis

Received: April 12, 2017     Accepted: October 04, 2017     Published: November 03, 2017

ABSTRACT

Emerging studies demonstrate the diagnostic utility of DNA methylation-based blood test for gastric cancer. The aim of the meta-analysis is to evaluate the accuracy of blood DNA methylation markers for detecting patients with gastric cancer. A systematic literature search to November 2016 that evaluated DNA methylation markers utilizing blood specimen to detect gastric cancer were selected to derive pooled sensitivities and specificities. 32 studies including 4,172 patients (gastric cancer (N = 2,098), control (N = 2,074)) met the study criteria. Overall sensitivity of DNA methylation-based blood test for detecting gastric cancer was 57% (95% CI 50–63%); specificity was 97% (95% CI 95–98%). Among patients who received plasma-based testing, sensitivity was 71% (95% CI 59–81%); specificity was 89% (95% CI 78–94%). Among patients who received serum-based testing, sensitivity was 50% (95% CI 43–58%); specificity was 98% (95% CI 96–99%). Using multiple methylated genes had sensitivity of 76% (95% CI 64–84%); specificity of 85% (95% CI 65–95%). DNA methylation test had sensitivity of 55% (95% CI 47–64%) and specificity of 96% (95% CI 92–98%) for detecting TNM stage I+II gastric cancer. In conclusion, blood-based DNA methylation test had high specificity but modest sensitivity for detecting gastric cancer. Evaluating multiple methylated genes or using plasma sample may improve the diagnostic sensitivity.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22613